<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/ar68.anc" start="11312" end="11317" sStart="11273" offset="39" sid="r7.1.use.v.0148" wn="1" wnkey="use%2:34:01::" text="Similar results are obtained using the genomic DNA-based assay, although these results cannot be interpreted in a C H -specific manner (data not shown)." />
    <s path="[OANC]/data/written_2/technical/biomed/ar68.anc" start="17478" end="17482" sStart="null" offset="28" sid="r11.true.j.0372" wn="5" wnkey="true%5:00:00:typical:00" text="Because these are true clonal expansions (ie increased numbers of B cells per specific clone), it is likely that the antigenic exposures are chronic and therefore are increasing the numbers of memory B cells reactive with these determinants." />
    <s path="[OANC]/data/written_2/technical/biomed/ar68.anc" start="6602" end="6607" sStart="null" offset="33" sid="r9.sense.n.0193" wn="2147483646" wnkey="null" text="cDNA (2?l) was amplified using a sense V H family-specific FR1 primer in conjunction with the appropriate antisense C H primer." />
    <s path="[OANC]/data/written_2/technical/biomed/ar68.anc" start="3375" end="3383" sStart="null" offset="306" sid="r11.refer.v.0240" wn="7" wnkey="refer%2:32:04::" text="The present study was designed to analyze further the level of clonal diversity in rheumatoid arthritis B cells by using the length of the third complementarity determining region (CDR3) of the rearranged heavy (H) chain variable region (V) gene as a marker (herein referred to as HCDR3)." />
    <s path="[OANC]/data/written_2/technical/biomed/ar68.anc" start="17515" end="17522" sStart="null" offset="65" sid="r8.number.n.0923" wn="1" wnkey="number%1:07:00::" text="Because these are true clonal expansions (ie increased numbers of B cells per specific clone), it is likely that the antigenic exposures are chronic and therefore are increasing the numbers of memory B cells reactive with these determinants." />
    <s path="[OANC]/data/written_2/technical/biomed/ar68.anc" start="11660" end="11667" sStart="null" offset="34" sid="r8.number.n.0371" wn="1" wnkey="number%1:07:00::" text="This could be a reflection of the numbers of V H genes present in the V H family being analyzed (it is more likely to see a non-Gaussian distribution in families with small numbers of individual genes) or of the state of activation of a specific clone (because activated B cells contain much higher levels of V gene messenger RNA than resting B cells)." />
    <s path="[OANC]/data/written_2/technical/biomed/ar68.anc" start="9213" end="9219" sStart="null" offset="7" sid="r9.normal.j.0979" wn="3" wnkey="normal%3:00:03::" text="During normal B cell development, the processes of gene segment recombination and coding end processing yield nucleotide HCDR3 lengths that are characteristic and virtually invariant for an individual B-cell clone." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/ar68.anc" start="26344" end="26350" sStart="null" offset="0" sid="null" wn="1" wnkey="mature%2:30:00::" text="It is likely that the B cells that &lt;b&gt;mature&lt;/b&gt; in these 'pseudogerminal centers' and those that we have identified in the present studies are responding to specific (auto)antigens." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/ar68.anc" start="26344" end="26350" sStart="null" offset="0" sid="null" wn="1" wnkey="mature%2:30:00::" text="It is likely that the B cells that &lt;b&gt;mature&lt;/b&gt; in these 'pseudogerminal centers' and those that we have identified in the present studies are responding to specific (auto)antigens." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/ar68.anc" start="26344" end="26350" sStart="null" offset="0" sid="null" wn="1" wnkey="mature%2:30:00::" text="It is likely that the B cells that &lt;b&gt;mature&lt;/b&gt; in these 'pseudogerminal centers' and those that we have identified in the present studies are responding to specific (auto)antigens." />
    <s path="[OANC]/data/written_2/technical/biomed/ar68.anc" start="2071" end="2076" sStart="null" offset="145" sid="r9.level.n.0464" wn="2" wnkey="level%1:26:01::" text="In contrast to the extensive studies of the clonal distribution of T cells in rheumatoid arthritis, much less is known about the level of B-cell diversity in this disease." />
    <s path="[OANC]/data/written_2/technical/biomed/ar68.anc" start="15975" end="15980" sStart="null" offset="22" sid="r9.level.n.0210" wn="1" wnkey="level%1:07:00::" text="An even more striking level of B-cell clonal dominance and expansion was seen when the genomic DNA-based assay was used to analyze B cells from the synovial fluid or synovial tissue (Figs 2and 3)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/ar68.anc" start="5475" end="5481" sStart="null" offset="0" sid="null" wn="1" wnkey="island%1:17:00::" text="One microgram of RNA was reverse transcribed to complementary (c)DNA using 200U Moloney murine leukemia virua (M-MLV) reverse transcriptase (GIBCO BRL Life Technologies, Grand &lt;b&gt;Island&lt;/b&gt;, NY, USA), 1U RNAse inhibitor (5 Prime 3 Prime, Boulder, CO, USA) and 20 pmol oligo dT primer in a total volume of 20 ?l." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/ar68.anc" start="5475" end="5481" sStart="null" offset="0" sid="null" wn="2147483646" wnkey="null" text="One microgram of RNA was reverse transcribed to complementary (c)DNA using 200U Moloney murine leukemia virua (M-MLV) reverse transcriptase (GIBCO BRL Life Technologies, Grand &lt;b&gt;Island&lt;/b&gt;, NY, USA), 1U RNAse inhibitor (5 Prime 3 Prime, Boulder, CO, USA) and 20 pmol oligo dT primer in a total volume of 20 ?l." />
    <s path="[OANC]/data/written_2/technical/biomed/ar68.anc" start="13098" end="13103" sStart="null" offset="181" sid="r10.help.v.0806" wn="3" wnkey="help%2:42:00::" text="Because DNA levels are not appreciably altered by cellular activation, however, the use of genomic DNA as well as cDNA from the same sample of B cells helps to distinguish these two processes." />
    <s path="[OANC]/data/written_2/technical/biomed/ar68.anc" start="1436" end="1441" sStart="null" offset="88" sid="r10.find.v.0516" wn="2" wnkey="find%2:39:02::" text="For example, clonal amplifications of CD8 +CD57 +T cells are frequently found in the T-cell repertoire of rheumatoid arthritis patients [ 4]." />
    <s path="[OANC]/data/written_2/technical/biomed/ar68.anc" start="25843" end="25852" sStart="null" offset="75" sid="r8.1.different.j.0427" wn="1" wnkey="different%3:00:00::" text="Furthermore, because it is unlikely that each joint would harbor a different foreign antigen, these B cells are most likely reacting with autoantigens generated locally, possibly by local tissue breakdown." />
    <s path="[OANC]/data/written_2/technical/biomed/ar68.anc" start="20514" end="20520" sStart="null" offset="146" sid="r10.common.j.0195" wn="3" wnkey="common%5:00:00:shared:00" text="Figures 2and 3illustrate data that suggest that there are expanded clones that are blood restricted, joint restricted, or are common to both compartments." />
    <s path="[OANC]/data/written_2/technical/biomed/ar68.anc" start="15459" end="15465" sStart="null" offset="93" sid="r10.common.j.0986" wn="4" wnkey="common%5:00:00:familiar:02" text="The genomic DNA-based assays in both patients indicated that clonal expansions are common in the blood of rheumatoid arthritis patients." />
    <s path="[OANC]/data/written_2/technical/biomed/ar68.anc" start="11259" end="11271" sStart="null" offset="271" sid="r11.combination.n.0676" wn="1" wnkey="combination%1:14:00::" text="This indicates that there are no dominant HCDR3 lengths that skew the Gaussian distribution, and therefore that there are no significant clonal expansions among the B cells that express most of these V H -C H combinations." />
    <s path="[OANC]/data/written_2/technical/biomed/ar68.anc" start="11505" end="11516" sStart="null" offset="28" sid="r11.combination.n.0687" wn="1" wnkey="combination%1:14:00::" text="In the V H 6-IgG combination (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/ar68.anc" start="21375" end="21387" sStart="null" offset="208" sid="r11.combination.n.0579" wn="1" wnkey="combination%1:14:00::" text="In this patient, the DNA-based assay provided examples of clonal expansions that were present in only one joint (eg the V H 3-J H and V H 5-J H combinations in Figure 4), and the companion cDNA-based assays indicated that in some instances these expansions were either activated or resting." />
  </sentences>
</list>